A previous study demonstrated that in skeletal muscle of rapamycin-treated mice (which develop diabetes-like symptoms), Irs1 was downregulated together with several other insulin signaling-linked genes through PRC1 recruitment and increased H3K27me3; this repression was dependent on the transcriptional regulator YY1 [36]. Here, INS is linked to diabetes mellitus.